These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2935814)

  • 21. [Fluoroquinolones, 10 years later].
    de la Blanchardière A; Carbon C
    Rev Prat; 1993 Sep; 43(14):1830-8. PubMed ID: 8310228
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sparfloxacin (a long-acting difluoroquinolone)--an antibacterial preparation with the broad spectrum activity].
    Padeĭskaia EN
    Antibiot Khimioter; 2002; 47(1):26-35. PubMed ID: 12077937
    [No Abstract]   [Full Text] [Related]  

  • 24. [Trovafloxacin in gynecology].
    Provenzano SL
    Medicina (B Aires); 1999; 59 Suppl 1():55-61. PubMed ID: 10436555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tested and new chemotherapy in infectious diseases].
    Hoigné R; Keller MF
    Schweiz Med Wochenschr; 1972 Jul; 102(27):933-40. PubMed ID: 4558901
    [No Abstract]   [Full Text] [Related]  

  • 26. 7-Azetidinylquinolones as antibacterial agents. Synthesis and structure-activity relationships.
    Frigola J; Parés J; Corbera J; Vañó D; Mercè R; Torrens A; Más J; Valentí E
    J Med Chem; 1993 Apr; 36(7):801-10. PubMed ID: 8464033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The choice of antimicrobial drugs.
    Med Lett Drugs Ther; 1976 Jan; 18(3):9-16. PubMed ID: 1256354
    [No Abstract]   [Full Text] [Related]  

  • 28. Pfizer settles with victims of Nigerian drug trial.
    Lenzer J
    BMJ; 2011 Aug; 343():d5268. PubMed ID: 21846712
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical studies of tosufloxacin on chronic bacterial prostatitis].
    Ikeuchi T; Kawamura N; Suzuki K; Onodera S; Osada T; Hirano A; Satomi Y; Yoshimura S; Yamamoto Y
    Hinyokika Kiyo; 1993 Jul; 39(7):673-8. PubMed ID: 8362691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the antibacterial activity of 1-substituted 1,4-dihydro-7-(2-(5-nitro-2-furyl)vinyl)-4-oxo-1,8-naphthyridine derivatives.
    Nagasaki S; Nakazawa N; Osada Y; Hashizume T; Oshima Y
    Chem Pharm Bull (Tokyo); 1972 Apr; 20(4):639-49. PubMed ID: 5045609
    [No Abstract]   [Full Text] [Related]  

  • 31. Antimicrobial agents for the prevention and treatment of abdominal infections: a new generation?
    Rotstein OD
    Am J Surg; 1998 Dec; 176(6A Suppl):80S-83S. PubMed ID: 9935262
    [No Abstract]   [Full Text] [Related]  

  • 32. [Trovafloxacine--a new quinolone with expanded action spectrum].
    Internist (Berl); 1998 Jun; 39(6 Suppl Trovafloxa):1-4. PubMed ID: 9693682
    [No Abstract]   [Full Text] [Related]  

  • 33. [Is trovafloxacin an antibiotic exclusively for the treatment of respiratory infections?].
    Garau J
    Enferm Infecc Microbiol Clin; 1998 Dec; 16 Suppl 2():43-6; discussion 47-52. PubMed ID: 10344098
    [No Abstract]   [Full Text] [Related]  

  • 34. The choice of antimicrobial drugs.
    Med Lett Drugs Ther; 1984 Mar; 26(656):19-26. PubMed ID: 6700533
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmacokinetics and safety of trovafloxacin].
    Frías J; de los Angeles Gálvez M
    Enferm Infecc Microbiol Clin; 1998 Dec; 16 Suppl 2():36-42; discussion 47-52. PubMed ID: 10344097
    [No Abstract]   [Full Text] [Related]  

  • 36. [The role of trovafloxacin in the treatment of nosocomial pneumonia].
    Mandell LA
    Medicina (B Aires); 1999; 59 Suppl 1():39-46. PubMed ID: 10436553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The choice of antimicrobial drugs.
    Med Lett Drugs Ther; 1978 Jan; 20(1):1-8. PubMed ID: 619230
    [No Abstract]   [Full Text] [Related]  

  • 38. Nigerian judge orders arrests of Pfizer officials.
    Lenzer J
    BMJ; 2008 Jan; 336(7634):11. PubMed ID: 18174580
    [No Abstract]   [Full Text] [Related]  

  • 39. [The antibacterial therapy of infectious lung lesions].
    Martsinovskiĭ VIu; Sil'vestrov VP; Semin SN
    Ter Arkh; 1990; 62(9):8-15. PubMed ID: 2281414
    [No Abstract]   [Full Text] [Related]  

  • 40. Antimicrobial peptide therapeutics for cystic fibrosis.
    Zhang L; Parente J; Harris SM; Woods DE; Hancock RE; Falla TJ
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2921-7. PubMed ID: 15980369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.